Page last updated: 2024-08-17

spironolactone and atrial natriuretic factor

spironolactone has been researched along with atrial natriuretic factor in 29 studies

Research

Studies (29)

TimeframeStudies, this research(%)All Research%
pre-19903 (10.34)18.7374
1990's6 (20.69)18.2507
2000's14 (48.28)29.6817
2010's6 (20.69)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Donker, AJ; Hackeng, WH; Meuwissen, SG; van Vliet, AA1
Currie, MG; Lanier-Smith, KL1
Abraham, WT; Dürr, JA; Hensen, J; Schrier, RW1
Fujii, J; Ishibashi, M; Nakaoka, H; Sekihara, H; Takaku, F; Yamaji, T1
Ichikawa, S; Kato, T; Kogure, M; Murata, K; Nakamura, T; Sakamaki, T; Sato, K; Tajima, Y1
Chen, JH; Hwang, SJ; Lai, YH; Tsai, JH1
D'Avanzo, L; Gazzotti, RM; Ghielmi, S; Poiesi, C; Usberti, M1
Villarreal, D; Weber, KT1
Fevery, J; Lijnen, P; Nevens, F; VanBilloen, H1
Delcayre, C; Desopper, C; Escoubet, B; Heymes, C; Oubénaïssa, A; Robert, V; Silvestre, JS; Swynghedauw, B1
Copolov, D; Huang, W; Lee, D; Lim, AT; Wang, L1
Barthelmebs, M; De Jong, W; De Kloet, ER; Grima, M; Imbs, JL; Rahmouni, K; Sibug, RM1
Hayashi, Y; Hiraishi, T; Kobayashi, Y; Ohtani, M1
Ahn, S; Duprez, D; Galanti, L; Gurné, O; Ketelslegers, JM; Robert, A; Rousseau, MF; Van Mieghem, W1
Bellorini, M; Desnos, M; Duboc, D; Funck, F; Guillard, N; Jourdain, P; Loiret, J; Thebault, B1
Fujii, M; Hayashi, M; Ishii, C; Maeda, K; Matsumoto, T; Ohnishi, M; Takayama, T; Tsutamoto, T; Tsutsui, T; Wada, A; Yamamoto, T1
Bauer, JA; Ghosh, S; Holycross, BJ; Kambara, A; Kwiatkowski, P; McCune, SA; Schanbacher, B; Wung, P1
Akioka, K; Iwao, H; Izumi, Y; Kim, S; Matsumoto, R; Nakamura, Y; Omura, T; Takeuchi, K; Yoshikawa, J; Yoshiyama, M1
Chen, YF; Feng, JA; Franco, V; Hasan, E; Li, P; Oparil, S; Perry, GJ; Wang, D1
de Resende, MM; Greene, AS; Kriegel, AJ1
Boluyt, MO; Cirrincione, G; Hwang, HS; McCormick, RJ; Thomas, DP1
Imagawa, K; Kawata, H; Kishimoto, I; Nakao, K; Naya, N; Saito, Y; Somekawa, S; Takeda, Y; Uemura, S; Zhang, Q1
Hayashi, T; Kimura, S; Kitada, K; Kitaura, Y; Kobayashi, K; Kurumazuka, D; Matsuda, H; Matsumoto, C; Matsumura, Y; Mori, T; Shirakawa, H1
Fujita, M; Hasegawa, K; Kawamura, T; Kita, T; Morimoto, T; Shimatsu, A; Sunagawa, Y; Takaya, T; Wada, H; Yoshida, Y1
Braga-Sobrinho, C; Leite-Dellova, DC; Mello-Aires, M1
Bonomo, C; Campos, DH; Cezar, MD; Cicogna, AC; Damatto, RL; Gimenes, R; Guizoni, DM; Lima, AR; Martinez, PF; Okoshi, K; Okoshi, MP; Pagan, LU; Rosa, CM1
Baba, HA; Frantz, S; Gaßner, B; Kuhn, M; Nakagawa, H; Nikolaev, VO; Oberwinkler, H; Saito, Y; Umbenhauer, S; Wagner, H1
Amancio, Gde C; Araujo, CM; de Assis, LV; Hermidorff, MM; Isoldi, MC; Lemos, Dda S; Silva, ME1
Asensio-López, MC; Caballero, L; Fernández-Del Palacio, MJ; Gimeno-Blanes, JR; Lax, A; Navarro-Peñalver, M; Pascual-Figal, DA; Pérez-Martínez, MT; Sánchez-Más, J1

Reviews

1 review(s) available for spironolactone and atrial natriuretic factor

ArticleYear
Role of aldosterone in congestive heart failure.
    Postgraduate medicine, 1993, Volume: 93, Issue:5

    Topics: Aldosterone; Atrial Natriuretic Factor; Heart Failure; Humans; Renin-Angiotensin System; Spironolactone

1993

Trials

2 trial(s) available for spironolactone and atrial natriuretic factor

ArticleYear
The effect of long-term treatment with spironolactone on variceal pressure in patients with portal hypertension without ascites.
    Hepatology (Baltimore, Md.), 1996, Volume: 23, Issue:5

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Ascites; Atrial Natriuretic Factor; Blood Pressure; Diuretics; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Plasma Volume; Propranolol; Renin; Reproducibility of Results; Spironolactone

1996
Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy.
    Journal of the American College of Cardiology, 2002, Nov-06, Volume: 40, Issue:9

    Topics: Aged; Aged, 80 and over; Angiotensin II; Atrial Natriuretic Factor; Endothelin-1; Female; Heart Failure; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Natriuretic Peptide, Brain; Spironolactone; Treatment Outcome

2002

Other Studies

26 other study(ies) available for spironolactone and atrial natriuretic factor

ArticleYear
Efficacy of low-dose captopril in addition to furosemide and spironolactone in patients with decompensated liver disease during blunted diuresis.
    Journal of hepatology, 1992, Volume: 15, Issue:1-2

    Topics: Adult; Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Captopril; Creatinine; Cyclic GMP; Diuresis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Furosemide; Humans; Kidney; Liver; Liver Cirrhosis; Male; Middle Aged; Renal Dialysis; Renin; Sodium; Spironolactone

1992
Glucocorticoid regulation of atrial natriuretic peptide receptors on cultured endothelial cells.
    Endocrinology, 1991, Volume: 129, Issue:5

    Topics: Animals; Atrial Natriuretic Factor; Autoradiography; Binding, Competitive; Cells, Cultured; Cross-Linking Reagents; Cyclic GMP; Dexamethasone; Endothelium, Vascular; Glucocorticoids; Mifepristone; Peptide Fragments; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface; Spironolactone

1991
Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention.
    American journal of nephrology, 1991, Volume: 11, Issue:6

    Topics: Aldosterone; Atrial Natriuretic Factor; Female; Heart Failure; Humans; Male; Middle Aged; Natriuresis; Potassium; Renin-Angiotensin System; Sodium; Sodium, Dietary; Spironolactone

1991
Plasma levels of atrial natriuretic peptide in primary aldosteronism and essential hypertension.
    The Journal of clinical endocrinology and metabolism, 1986, Volume: 63, Issue:4

    Topics: Adult; Atrial Natriuretic Factor; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Spironolactone

1986
Role of atrial natriuretic peptide in mineralocorticoid escape phenomenon in patients with primary aldosteronism.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1987, Volume: 185, Issue:4

    Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Desoxycorticosterone; Humans; Hydrocortisone; Hyperaldosteronism; Middle Aged; Mineralocorticoids; Natriuresis; Potassium; Renin; Spironolactone

1987
Plasma atrial natriuretic peptide (ANP) in primary aldosteronism.
    Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association, 1988, Volume: 87, Issue:9

    Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Atrial Natriuretic Factor; Female; Furosemide; Humans; Hyperaldosteronism; Hyperplasia; Isotonic Solutions; Male; Middle Aged; Radioimmunoassay; Sodium Chloride; Spironolactone

1988
Considerations on the sodium retention in nephrotic syndrome.
    American journal of nephrology, 1995, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Atrial Natriuretic Factor; Blood Volume; Diuretics; Humans; Kidney; Lithium; Middle Aged; Nephrotic Syndrome; Peptide Fragments; Renin-Angiotensin System; Serum Albumin; Sodium; Sodium, Dietary; Spironolactone

1995
Different regulation of cardiac and renal corticosteroid receptors in aldosterone-salt treated rats: effect of hypertension and glucocorticoids.
    Journal of molecular and cellular cardiology, 2000, Volume: 32, Issue:7

    Topics: Adrenalectomy; Age Factors; Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Blotting, Western; Collagen; Glucocorticoids; Heart; Hypertension; Kidney; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Rats; Rats, Inbred SHR; Rats, Wistar; Receptors, Steroid; RNA, Complementary; Sodium Chloride; Spironolactone; Time Factors

2000
Glucocorticoid modulation of dopamine mediated effects on hypothalamic atrial natriuretic factor neurons.
    Molecular psychiatry, 2000, Volume: 5, Issue:3

    Topics: Animals; Animals, Newborn; Atrial Natriuretic Factor; Cells, Cultured; Desoxycorticosterone; Dexamethasone; Dopamine; Down-Regulation; Gene Expression Regulation; Glucocorticoids; Hypothalamus; Mifepristone; Neurons; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Spironolactone; Transcription, Genetic

2000
Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
    European journal of pharmacology, 2002, Feb-02, Volume: 436, Issue:3

    Topics: Angiotensinogen; Animals; Atrial Natriuretic Factor; Blood Pressure; Brain; Chlorides; Desoxycorticosterone; Diuresis; Hypertension; Injections, Intraventricular; Kidney; Male; Mineralocorticoid Receptor Antagonists; Potassium; Rats; Rats, Wistar; Receptors, Mineralocorticoid; RNA, Messenger; Sodium; Sodium Chloride, Dietary; Spironolactone; Time Factors; Transcription, Genetic

2002
Postoperative synthetic human atrial natriuretic peptide infusion and oral spironolactone administration for a patient with giant atria and low plasma level of atrial natriuretic peptide.
    The Journal of thoracic and cardiovascular surgery, 2002, Volume: 124, Issue:1

    Topics: Administration, Oral; Atrial Natriuretic Factor; Cardiopulmonary Bypass; Female; Heart Failure; Humans; Infusions, Intravenous; Middle Aged; Mitral Valve Stenosis; Postoperative Care; Spironolactone; Tricuspid Valve Insufficiency

2002
Bedside B-type natriuretic peptide and functional capacity in chronic heart failure.
    European journal of heart failure, 2003, Volume: 5, Issue:2

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Biomarkers; Carbazoles; Carvedilol; Chronic Disease; Diuretics; Dose-Response Relationship, Drug; Follow-Up Studies; France; Furosemide; Heart Failure; Humans; Incidence; Lisinopril; Middle Aged; Natriuretic Peptide, Brain; Propanolamines; Severity of Illness Index; Spironolactone; Stroke Volume; Treatment Outcome

2003
Transcardiac gradient of aldosterone before and after spironolactone in patients with congestive heart failure.
    Journal of cardiovascular pharmacology, 2003, Volume: 41 Suppl 1

    Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Patients; Spironolactone

2003
Combined effects of low-dose oral spironolactone and captopril therapy in a rat model of spontaneous hypertension and heart failure.
    Journal of cardiovascular pharmacology, 2003, Volume: 41, Issue:6

    Topics: Administration, Oral; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Captopril; Diuresis; Drug Therapy, Combination; Fibrosis; Heart Failure; Heart Ventricles; Hypertension; Hypertrophy; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Organ Size; Rats; Rats, Inbred SHR; Spironolactone; Time Factors; Ultrasonography

2003
Effects of aldosterone receptor antagonist and angiotensin II type I receptor blocker on cardiac transcriptional factors and mRNA expression in rats with myocardial infarction.
    Circulation journal : official journal of the Japanese Circulation Society, 2004, Volume: 68, Issue:4

    Topics: Animals; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Collagen Type I; Collagen Type III; Drug Synergism; Echocardiography; Gene Expression Profiling; Heart; Male; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; NF-kappa B; Rats; Rats, Wistar; Receptors, Angiotensin; Receptors, Mineralocorticoid; RNA, Messenger; Spironolactone; Tetrazoles; Transcription Factor AP-1; Ventricular Function, Left; Ventricular Remodeling

2004
Eplerenone prevents adverse cardiac remodelling induced by pressure overload in atrial natriuretic peptide-null mice.
    Clinical and experimental pharmacology & physiology, 2006, Volume: 33, Issue:9

    Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Eplerenone; Heart; Hypertrophy; Male; Mice; Mice, Knockout; Myocardium; Spironolactone; Ventricular Remodeling

2006
Combined effects of low-dose spironolactone and captopril therapy in a rat model of genetic hypertrophic cardiomyopathy.
    Journal of cardiovascular pharmacology, 2006, Volume: 48, Issue:6

    Topics: Administration, Oral; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Congenic; Atrial Natriuretic Factor; Blood Pressure; Captopril; Cardiomyopathy, Hypertrophic; Disease Models, Animal; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echocardiography; Injections, Subcutaneous; Myocardium; Organ Size; Random Allocation; Rats; Rats, Inbred Strains; Spironolactone; Ventricular Function, Left; Weight Loss

2006
Aldosterone antagonism fails to attenuate age-associated left ventricular fibrosis.
    The journals of gerontology. Series A, Biological sciences and medical sciences, 2007, Volume: 62, Issue:4

    Topics: Aging; Aldosterone; Animals; Atrial Natriuretic Factor; Collagen; Collagen Type III; Female; Fibrosis; Gene Expression; Heart Ventricles; Mineralocorticoid Receptor Antagonists; Myocardium; Myosin Heavy Chains; Rats; Rats, Inbred F344; RNA, Messenger; Spironolactone; Tissue Distribution; Ventricular Myosins

2007
The specific mineralocorticoid receptor blocker eplerenone attenuates left ventricular remodeling in mice lacking the gene encoding guanylyl cyclase-A.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2008, Volume: 31, Issue:6

    Topics: Animals; Atrial Natriuretic Factor; Eplerenone; Guanylate Cyclase; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mineralocorticoid Receptor Antagonists; Spironolactone; Systole; Ventricular Remodeling

2008
Dietary salt restriction activates mineralocorticoid receptor signaling in volume-overloaded heart failure.
    European journal of pharmacology, 2009, Nov-25, Volume: 623, Issue:1-3

    Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Body Weight; Cell Size; Contraindications; Diet, Sodium-Restricted; Endomyocardial Fibrosis; Heart; Heart Failure; Hemodynamics; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Organ Size; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Signal Transduction; Spironolactone; Transforming Growth Factor beta; Tyrosine; Ventricular Remodeling

2009
Aldosterone signaling associates with p300/GATA4 transcriptional pathway during the hypertrophic response of cardiomyocytes.
    Circulation journal : official journal of the Japanese Circulation Society, 2010, Volume: 74, Issue:1

    Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Chlorocebus aethiops; COS Cells; Disease Models, Animal; E1A-Associated p300 Protein; GATA4 Transcription Factor; Hypertrophy; Mice; Myocytes, Cardiac; NIH 3T3 Cells; Phenylephrine; Rats; Receptors, Mineralocorticoid; Signal Transduction; Spironolactone; Transfection

2010
Action of ANP on the nongenomic dose-dependent biphasic effect of aldosterone on NHE1 in proximal S3 segment.
    The Journal of steroid biochemistry and molecular biology, 2012, Volume: 128, Issue:3-5

    Topics: Acid-Base Equilibrium; Aldosterone; Ammonium Chloride; Animals; Atrial Natriuretic Factor; Calcium Signaling; Chelating Agents; Hydrogen-Ion Concentration; In Vitro Techniques; Kidney Tubules, Proximal; Kinetics; Male; Microdissection; Mifepristone; Mineralocorticoid Receptor Antagonists; Osmolar Concentration; Rats; Rats, Wistar; Receptors, Glucocorticoid; Sodium-Hydrogen Exchanger 1; Sodium-Hydrogen Exchangers; Spironolactone

2012
Aldosterone blockade reduces mortality without changing cardiac remodeling in spontaneously hypertensive rats.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2013, Volume: 32, Issue:5

    Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Electrocardiography; Gene Expression Regulation; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Papillary Muscles; Rats; Rats, Inbred SHR; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Spironolactone; Ventricular Function, Left; Ventricular Remodeling

2013
Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation.
    Circulation. Heart failure, 2014, Volume: 7, Issue:5

    Topics: Animals; Atrial Natriuretic Factor; Blotting, Western; Cardiomyopathy, Dilated; Connective Tissue Growth Factor; Disease Models, Animal; DNA; Eplerenone; Gene Expression Regulation; HEK293 Cells; Humans; Immunohistochemistry; Mice; Mice, Knockout; Microscopy, Confocal; Mineralocorticoid Receptor Antagonists; Myocytes, Cardiac; Receptors, Mineralocorticoid; Reverse Transcriptase Polymerase Chain Reaction; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Signal Transduction; Spironolactone; Ventricular Remodeling

2014
Rapid effects of aldosterone in primary cultures of cardiomyocytes - do they suggest the existence of a membrane-bound receptor?
    Journal of receptor and signal transduction research, 2016, Volume: 36, Issue:5

    Topics: A Kinase Anchor Proteins; Aldosterone; Animals; Atrial Natriuretic Factor; Cyclic AMP; Egtazic Acid; Heart Failure; Humans; Hypertrophy; Mitogen-Activated Protein Kinase 7; Myocytes, Cardiac; Phosphorylation; Primary Cell Culture; Protein Kinase C; Rats; Receptors, Mineralocorticoid; Signal Transduction; Spironolactone

2016
The TBX1 Transcription Factor in Cardiac Remodeling After Myocardial Infarction.
    Revista espanola de cardiologia (English ed.), 2016, Volume: 69, Issue:11

    Topics: Actinin; Animals; Atrial Natriuretic Factor; Blotting, Western; Eplerenone; Fibrosis; Gene Expression Regulation, Developmental; Heart; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Myocardium; Myosin Heavy Chains; Natriuretic Peptide, Brain; Rats; Real-Time Polymerase Chain Reaction; RNA, Messenger; Spironolactone; T-Box Domain Proteins; Ventricular Remodeling

2016